Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShort-Term Debt issuances
Growth Metrics
Income Statement
Others
Ratios

P3 Health Partners (PIIIW) Change in Cash (2021 - 2025)

P3 Health Partners' Change in Cash history spans 5 years, with the latest figure at -$12.7 million for Q4 2025.

  • For Q4 2025, Change in Cash rose 47.26% year-over-year to -$12.7 million; the TTM value through Dec 2025 reached -$18.3 million, down 677.49%, while the annual FY2025 figure was -$18.3 million, 677.49% down from the prior year.
  • Change in Cash reached -$12.7 million in Q4 2025 per PIIIW's latest filing, down from -$865000.0 in the prior quarter.
  • In the past five years, Change in Cash ranged from a high of $57.1 million in Q2 2023 to a low of -$46.8 million in Q2 2022.
  • Average Change in Cash over 5 years is -$7.5 million, with a median of -$10.1 million recorded in 2023.
  • Peak YoY movement for Change in Cash: crashed 393.57% in 2022, then skyrocketed 222.06% in 2023.
  • A 5-year view of Change in Cash shows it stood at $672083.0 in 2021, then crashed by 2615.17% to -$16.9 million in 2022, then rose by 2.35% to -$16.5 million in 2023, then tumbled by 45.38% to -$24.0 million in 2024, then surged by 47.26% to -$12.7 million in 2025.
  • Per Business Quant, the three most recent readings for PIIIW's Change in Cash are -$12.7 million (Q4 2025), -$865000.0 (Q3 2025), and -$2.0 million (Q2 2025).